JP2018528175A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018528175A5 JP2018528175A5 JP2018504666A JP2018504666A JP2018528175A5 JP 2018528175 A5 JP2018528175 A5 JP 2018528175A5 JP 2018504666 A JP2018504666 A JP 2018504666A JP 2018504666 A JP2018504666 A JP 2018504666A JP 2018528175 A5 JP2018528175 A5 JP 2018528175A5
- Authority
- JP
- Japan
- Prior art keywords
- hours
- less
- plasma concentration
- etol
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036470 plasma concentration Effects 0.000 claims 32
- 238000001727 in vivo Methods 0.000 claims 21
- 239000003814 drug Substances 0.000 claims 4
- 239000000178 monomer Substances 0.000 claims 4
- 230000037317 transdermal delivery Effects 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 229920000193 polymethacrylate Polymers 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims 2
- 230000008034 disappearance Effects 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 125000005250 alkyl acrylate group Chemical group 0.000 claims 1
- -1 alkyl methacrylate Chemical compound 0.000 claims 1
- 125000004432 carbon atom Chemical group C* 0.000 claims 1
- 230000004907 flux Effects 0.000 claims 1
- 239000012458 free base Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000003961 penetration enhancing agent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1513441.4 | 2015-07-30 | ||
| GBGB1513441.4A GB201513441D0 (en) | 2015-07-30 | 2015-07-30 | Transdermal delivery system |
| PCT/GB2016/052307 WO2017017452A1 (en) | 2015-07-30 | 2016-07-28 | Transdermal delivery system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018528175A JP2018528175A (ja) | 2018-09-27 |
| JP2018528175A5 true JP2018528175A5 (https=) | 2019-09-12 |
Family
ID=54062902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018504666A Pending JP2018528175A (ja) | 2015-07-30 | 2016-07-28 | 経皮送達系 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20180221299A1 (https=) |
| EP (1) | EP3328431A1 (https=) |
| JP (1) | JP2018528175A (https=) |
| KR (1) | KR20180035859A (https=) |
| CN (1) | CN108025077A (https=) |
| AR (1) | AR105533A1 (https=) |
| AU (1) | AU2016298761A1 (https=) |
| BR (1) | BR112018001615A2 (https=) |
| CA (1) | CA2994103A1 (https=) |
| GB (1) | GB201513441D0 (https=) |
| IL (1) | IL256995A (https=) |
| MA (1) | MA42521A (https=) |
| MX (1) | MX2018001318A (https=) |
| SG (1) | SG10201913254RA (https=) |
| TW (1) | TW201713340A (https=) |
| WO (1) | WO2017017452A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10231248A (ja) * | 1997-02-19 | 1998-09-02 | T T S Gijutsu Kenkyusho:Kk | ジヒドロエトルフィン含有経皮吸収型製剤 |
| US6716449B2 (en) * | 2000-02-08 | 2004-04-06 | Euro-Celtique S.A. | Controlled-release compositions containing opioid agonist and antagonist |
| KR101159828B1 (ko) * | 2003-04-30 | 2012-07-04 | 퍼듀 퍼머 엘피 | 활성제 구성요소 및 활성제 층의 원위부에 억제제 구성요소를 포함하는 내변조성 경피제형 |
| TWI541246B (zh) * | 2008-12-08 | 2016-07-11 | 歐陸斯迪公司 | 二氫羥戊甲嗎啡 |
-
2015
- 2015-07-30 GB GBGB1513441.4A patent/GB201513441D0/en not_active Ceased
-
2016
- 2016-07-28 EP EP16747572.2A patent/EP3328431A1/en not_active Withdrawn
- 2016-07-28 WO PCT/GB2016/052307 patent/WO2017017452A1/en not_active Ceased
- 2016-07-28 CA CA2994103A patent/CA2994103A1/en not_active Abandoned
- 2016-07-28 SG SG10201913254RA patent/SG10201913254RA/en unknown
- 2016-07-28 AU AU2016298761A patent/AU2016298761A1/en not_active Abandoned
- 2016-07-28 MA MA042521A patent/MA42521A/fr unknown
- 2016-07-28 BR BR112018001615A patent/BR112018001615A2/pt not_active IP Right Cessation
- 2016-07-28 CN CN201680054263.8A patent/CN108025077A/zh active Pending
- 2016-07-28 KR KR1020187005833A patent/KR20180035859A/ko not_active Withdrawn
- 2016-07-28 JP JP2018504666A patent/JP2018528175A/ja active Pending
- 2016-07-28 US US15/748,548 patent/US20180221299A1/en not_active Abandoned
- 2016-07-28 MX MX2018001318A patent/MX2018001318A/es unknown
- 2016-07-29 TW TW105124084A patent/TW201713340A/zh unknown
- 2016-07-29 AR ARP160102318A patent/AR105533A1/es unknown
-
2018
- 2018-01-18 IL IL256995A patent/IL256995A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101528207B (zh) | 用于活性物质丁丙诺啡的给药的透皮治疗系统 | |
| AU2010319065B2 (en) | Pharmaceutical composition for external use | |
| JP2017524685A5 (https=) | ||
| JP2015528471A5 (https=) | ||
| EA201591124A1 (ru) | Трансдермальная система доставки | |
| JP2016516040A5 (https=) | ||
| FI3362065T3 (fi) | Ivosidenibiä, sytarabiinia ja daunorubisiinia tai idarubisiinia käsittävä yhdistelmähoito akuutin myelooisen leukemian hoitamiseksi | |
| PT1589956E (pt) | Granisetron transdérmico | |
| JP2016504368A5 (https=) | ||
| CA3019769C (en) | Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa | |
| JP2016502989A5 (https=) | ||
| JP2017513809A5 (https=) | ||
| CN104955516B (zh) | 延长丁丙诺啡经皮递送组合物及其使用方法 | |
| RU2017120184A (ru) | Лекарства для замедления течения болезни паркинсона | |
| JP2017515871A (ja) | 安定性を向上させたロチゴチン含有経皮吸収製剤 | |
| JP2020536953A5 (https=) | ||
| JP2003528037A (ja) | 気管支拡張剤ツロブテロールを皮膚から投与するための塩酸ツロブテロールを含む経皮治療システム | |
| JP2000178186A (ja) | 経皮吸収テ―プ剤 | |
| TW200902090A (en) | Transdermal administration device for bisoprolol | |
| JP2008538753A5 (ja) | 骨の老化または骨粗しょう症の治療または予防用組成物 | |
| ES2629063T3 (es) | Preparación de parche | |
| US20170071880A1 (en) | Selegiline transdermal system | |
| JP2018528175A5 (https=) | ||
| JP2021525758A5 (https=) | ||
| JPWO2022045336A5 (https=) |